Company Description
Charlotte's Web Holdings, Inc. is involved in the farming, manufacture, marketing, and sale of hemp-derived cannabidiol (CBD) wellness products.
The company's products categories include hemp extract oil tinctures, such as liquid products; gummies; and capsules, CBD topical creams, and lotions, as well as products for pets under the Charlotte's Web, ReCreate, CBD Medic, CBD Clinic, and Harmony Hemp brands.
Its products contain naturally occurring phytocannabinoids, including CBD, cannabichromene, cannabigerol, cannabinol, terpenes, flavonoids, and other beneficial hemp compounds.
The company distributes its products through retail outlets and health care practitioners, as well as online through its website.
It has a collaboration between its CW Labs science division and Colorado State University's College of Agricultural Sciences; and scientific collaboration with McLean Hospital.
The company was formerly known as Stanley Brothers Holdings Inc. and changed its name to Charlotte's Web Holdings, Inc. in July 2018.
The company was founded in 2013 and is headquartered in Louisville, Colorado.
| Country | Colombia |
| Founded | 2018 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 164 |
| CEO | William J. Morachnick |
Contact Details
Address: 700 Tech Court Louisville, Colorado 80027 United States | |
| Phone | 1-720-617-7303 |
| Website | charlottesweb.com |
Stock Details
| Ticker Symbol | CWBHF |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001750155 |
| CUSIP Number | 16106R109 |
| ISIN Number | CA16106R1091 |
| Employer ID | 98-1508633 |
| SIC Code | 0100 |
Key Executives
| Name | Position |
|---|---|
| Jared Stanley | Co-Founder and Chief Commercial Officer |
| Greg Gould | Chief Administration Officer |
| Stephen David Rogers | Senior Vice President, General Counsel and ?Corporate Secretary. |
| William J. Morachnick | Chief Executive Officer and Non-Independent Director |
| Jessica Saxton | Chief Financial Officer |
| Sarah Cambridge | Corporate Controller and Chief Accounting Officer |
| Dr. Marcel Bonn-Miller Ph.D. | Chief Scientific Officer |
| Cory Pala | Director of Investor Relations |
| Kelly Shea | Senior Vice President of Government Affairs and Corporate Communications |
| Andrew Shafer | Chief Marketing Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 21, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Mar 21, 2024 | 10-K | Annual Report |
| Mar 21, 2024 | 8-K | Current Report |
| Feb 14, 2024 | 8-K | Current Report |
| Feb 7, 2024 | 8-K | Current Report |
| Feb 5, 2024 | 8-K | Current Report |
| Jan 2, 2024 | 8-K | Current Report |
| Nov 9, 2023 | 8-K | Current Report |
| Nov 9, 2023 | 10-Q | Quarterly Report |
| Oct 12, 2023 | 8-K | Current Report |